Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, ...

Hims & Hers stock price has greatly performed this year as it continued to disrupt the healthcare industry. HIMS has jumped ...

It’s been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling.

Hims & Hers Health (NYSE: HIMS) stock is on a downward trend on both macro trends and news about GLP-1s. But this is still a ...

Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no ...

Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS ...

Hims & Hers Health (NYSE:HIMS) is rewriting the telehealth playbook while its competitors scramble. With a 200% YTD surge, the company's diversified approachcombining virtual consultations ...

In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 3348.53 with a ...

Hers provides medications for weight loss, hair loss, mental health, sexual health, and more. Here’s the lowdown on how it works and what it costs. Share on Pinterest Hers, a part of the Hims ...

The Food and Drug Administration re-evaluated its determination from October 2 on the status of the tirzepatide shortage. Eli Lilly’s (LLY) ...